Radical improvements in diagnostic services, cancer education, and training, and policies that encourage integration between primary and specialist care, primary care doctors could hold the key to meeting the growing demand for cancer care.
In infrequent situations in which coagulation factor replacement is needed, plasma can be vital for patients with cancer. Granulocyte transfusions may sometimes be considered for recalcitrant infections in patients with neutropenia. This article summarizes the current clinical indications and uses of RBCs, plasma, and granulocytes.
A weakened strain of Clostridium novyi-NT bacteria killed cancer cells when injected into tumors, investigators reported.
Presence of residual vein thrombosis may help determine the optimal duration of anticoagulant therapy in cancer patients with deep vein thrombosis (DVT) of the lower limbs.
HIV-infected individuals with cancer are less likely to receive treatment, according to a study published online in the Journal of Clinical Oncology.
Researchers have found that as antihistamines do their job, they also interfere with the function of myeloid-derived suppressor cells—a type of cell known to hinder the body’s ability to combat tumors.
Evidence to support reimbursement for proton-beam therapy remains limited to several relatively uncommon cancers.
Despite claims suggesting otherwise, inappropriate cancer patient demands are few and very rarely lead to unnecessary tests and treatments from their health care providers, according to new results.
A new tumor-tracking technique delivers higher levels of radiation to moving tumors while sparing healthy tissue in lung cancer patients. This technique is moving closer to the clinic.
Radiolabeled agents are powerful tools to target and kill cancer cells. Three recent studies explore the benefits of adding radionuclide therapy when treating metastatic cancer.
